sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
4-May-2016 17:18
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 201-225 out of 1226.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>

Public Release: 25-Jan-2016
Cell
Researchers may hold key to developing a single treatment against several types of Ebola
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola. The study is currently available in Cell.
NIH/National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Defense Threat Reduction Agency

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 25-Jan-2016
Funding received to develop device to help save the lives of new mothers worldwide
Professor of International Maternal Health Andrew Weeks from the Institute of Translational medicine has been awarded £850,000 to further develop an award-winning device that could save the lives of women all over the world.
National Institute of Health Research

Contact: Simon Wood
simon.wood@liverpool.ac.uk
44-151-794-8356
University of Liverpool

Public Release: 21-Jan-2016
Cell
Antibodies may provide 'silver bullet' for Ebola viruses
Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) reported today in the journal Cell that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.
NIH/National Institute of Allergy and Infectious Diseases, Defense Threat Reduction Agency award

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 21-Jan-2016
The BMJ
Should India's quacks be trained to deliver basic patient care?
Should unqualified practitioners be trained to deliver basic patient care to alleviate India's doctor shortage, asks a special report published by The BMJ today?

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ

Public Release: 21-Jan-2016
PLOS Pathogens
Immune response differences might determine severity of West Nile Virus disease
While most West Nile Virus infections in humans are asymptomatic and go unnoticed, the virus causes serious and sometimes fatal neurologic illness in some people. A study published on Jan. 21 in PLOS Pathogens suggests that an exaggerated and abnormal immune response contributes to the development of neurologic symptoms following West Nile Virus infection.

Contact: Eddie James
ejames@benaroyaresearch.org
PLOS

Public Release: 20-Jan-2016
CSU's BioMARC helps advance vaccines for Department of Defense
Colorado State University's Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded a 10-month, $4.6 million contract funded by the Department of Defense (DoD) to help develop and manufacture new vaccines to fight encephalitic viruses that cause inflammation of the brain.
Department of Defense

Contact: Jeff Dodge
jeff.dodge@colostate.edu
970-491-4251
Colorado State University

Public Release: 19-Jan-2016
Biochemical and Biophysical Research Communications
Infant-friendly flu vaccine developed with key protein
According to the World Health Organization, influenza causes serious illness among millions of people each year, resulting in 250,000 to 500,000 deaths. Those most at risk include infants younger than six months, because they cannot be vaccinated against the disease. Now, researchers at the University of Missouri School of Medicine have identified a naturally occurring protein that, when added to the flu vaccine, may offer protection to babies during their first months of life.
National Institutes of Health, University of Missouri Research Board, Leda J. Sears Trust

Contact: Jeff Hoelscher
hoelscherj@missouri.edu
573-884-1608
University of Missouri-Columbia

Public Release: 19-Jan-2016
European Respiratory Journal
Women at higher risk to develop chronic obstructive pulmonary disease
Researchers from Lund University Sweden have through a new diagnostic method been able to show that the risk of developing chronic obstructive pulmonary disease could be twice as high for women as it is for men. This means that being a woman may be an independent risk factor for developing this disease.

Contact: Cecilia Schubert
cecilia.schubert@kommunikation.lu.se
46-708-661-383
Lund University

Public Release: 19-Jan-2016
Circulation
Text messages can help reduce blood pressure
Study shows text message reminders help people stick to their prescribed treatment with improved blood pressure as a result.

Contact: Tom Calver
news.office@admin.ox.ac.uk
44-186-527-0046
University of Oxford

Public Release: 19-Jan-2016
Journal of Infectious Diseases
Immunity genes could protect some from E. coli while others fall ill
When a child comes home from preschool with a stomach bug that threatens to sideline the whole family for days, why do some members of the family get sick while others are unscathed? According to a Duke Health study published Jan. 19, 2016 in the Journal of Infectious Diseases, a person's resistance to certain germs, specifically E. coli bacteria, could come down to their very DNA.
United States Advanced Research Projects Agency, Program for Appropriate Technology

Contact: Samiha Khanna
samiha.khanna@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 18-Jan-2016
Proceedings of the National Academy of Sciences
Scientists take steps to make weak TB drugs strong again
Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.
European Molecular Biology Organization, US Department of Veterans Affairs, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Cancer Institute, NIH/National Institute of General Medical Sciences, and others

Contact: Catherine Gara
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine

Public Release: 18-Jan-2016
The Lancet
Slow progress on stillbirth prevention: Parents of 2.6 million babies suffer in silence each year
More than 2.6 million stillbirths continue to occur globally every year with very slow progress made to tackle this 'silent problem,' according to a major new series of research on ending preventable stillbirths.

Contact: Jenny Orton
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 17-Jan-2016
Dissertations
Increased childbirth at Indian health facilities led to no matching reduction in maternal death
To reduce maternal and neo-natal deaths, India launched a cash transfer program in 2005 that provides monetary incentives for women to give birth in health facilities instead of at home. While the program successfully increased the use of health facilities for child birth, it did not reduce maternal deaths as much, especially in poor areas. This is according to a doctoral dissertation published at Umeå University.

Contact: Daniel Harju
daniel.harju@umu.se
46-725-522-918
Umea University

Public Release: 15-Jan-2016
Cell
UGA researchers discover how trypanosome parasites communicate with each other
While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery. The UGA researchers discovered that long filaments--that look like beads on a string -- form by budding from the flagellum of African trypanosomes and then release pieces of the parasite into the host.
National Institutes of Health

Contact: Stephanie Schupska
schupska@uga.edu
706-542-6927
University of Georgia

Public Release: 14-Jan-2016
Dengue vaccine enters phase 3 trial in Brazil
A large-scale clinical trial to evaluate whether a candidate vaccine can prevent the mosquito-borne illness dengue fever has been launched in Brazil. The vaccine, TV003, was developed by scientists in the laboratory of Stephen Whitehead, Ph.D., at NIAID. The Butantan Institute, a non-profit producer of immunobiologic products for Brazil, licensed the NIAID dengue vaccine technology and is sponsoring the placebo-controlled, multi-center Phase 3 trial using test vaccine produced in Sao Paulo.
National Institute of Allergy and Infectious Diseases (NIAID)

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 14-Jan-2016
The Lancet
Zika virus has potential to spread rapidly through Americas
The Zika virus, possibly linked to serious birth defects in Brazil, has the potential to spread within the Americas, including parts of the US, according to an international team of researchers who track the spread of infectious diseases.
Canadian Institutes of Health Research, Wellcome Trust, Bill & Melinda Gates Foundation, RAPIDD/Science & Technology Directorate, US Department of Homeland Security, NIH/Fogarty International Center

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 13-Jan-2016
New report: Future pandemics pose massive risks to human lives, global economic security
Infectious disease outbreaks that turn into epidemics or pandemics can kill millions of people and cause trillions of dollars of damage to economic activity, says a new report from the international, independent Commission on a Global Health Risk Framework for the Future.

Contact: News Office
news@nas.edu
202-334-2138
National Academy of Sciences

Public Release: 13-Jan-2016
Trauma team members face risk of 'compassion fatigue' and burnout
Trauma team members are at risk of compassion fatigue and burnout syndrome, as supported by the new research by Gina M. Berg, Ph.D., M.B.A., of University of Kansas School of Medicine-Wichita and colleagues. Authors identify some 'stress triggers' contributing to these risks, and make recommendations to help trauma teams cope with secondary traumatic stress, reports a study in the January issue of Journal of Trauma Nursing. The journal is published by Wolters Kluwer.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 13-Jan-2016
Nature Communications
Protein patterns -- a new tool for studying sepsis
Researchers from Lund University and the University of Zurich have developed a way to use mass spectrometry to measure hundreds of proteins in a single blood sample. With the help of protein patterns it is then possible to determine the severity of a patient's sepsis (blood poisoning) condition and which organs have been damaged. The method is presented in an article in Nature Communications.

Contact: Cecilia Schubert
cecilia.schubert@kommunikation.lu.se
46-046-222-7646
Lund University

Public Release: 13-Jan-2016
New England Journal of Medicine
Mosquito net safe to use in inguinal hernia repair
Sterilized mosquito nets can replace costly surgical meshes in the repair of inguinal (groin) hernias without further risk to the patients, according to a new Swedish-Ugandan study. This makes mosquito nets a good alternative for close to 200 million people in low-income countries suffering from untreated groin hernias.
Swedish Society of Medicine, Swedish Research Council, Swedish Rotary, Church of Sweden, Capio Research Foundation, and others

Contact: KI Press Office
pressinfo@ki.se
46-085-248-6077
Karolinska Institutet

Public Release: 13-Jan-2016
BioScience
New insights into animal-borne disease outbreaks
To better understand the dynamics of zoonotic diseases, researchers have examined the epidemiology of plague among black-tailed prairie dogs. Their work points to biases that may threaten efforts to better characterize the vectors and transmission of diseases such as Ebola, Middle East respiratory syndrome, and others.
Short Grass Steppe Long Term Ecological Research Grants, Ecology of Infectious Diseases Programs

Contact: James Verdier
jverdier@aibs.org
205-286-8626
American Institute of Biological Sciences

Public Release: 12-Jan-2016
Heliyon
Experts call for more tailored liver cancer care in developing countries
International liver cancer guidelines could be preventing patients from getting life-saving treatments in developing countries, according to a new study published in the journal Heliyon. The authors of the research are calling for treatment guidelines that are more tailored to developing countries, to help save lives.

Contact: Mary Beth O'Leary
m.oleary@elsevier.com
44-020-742-44343
Elsevier

Public Release: 11-Jan-2016
The Lancet
The Institut Pasteur in French Guiana publishes the first complete genome sequence of the Zika virus
Having confirmed the first cases of infection in Suriname then in French Guiana, the Institut Pasteur in French Guiana has sequenced the complete genome of the Zika virus, which is responsible for an unprecedented epidemic currently sweeping through the tropical regions of the Americas. Published in The Lancet medical journal, the analysis of this sequence shows almost complete homology with the strains responsible for the epidemic that occurred in the Pacific in 2013 and 2014.

Contact: Myriam Rebeyrotte
presse@pasteur.fr
Institut Pasteur

Public Release: 11-Jan-2016
Decades-long quest to beat river blindness edges towards vaccine
The world's first vaccine for a disease that causes misery for millions in Africa could be tested within five years.

Contact: Andrew Moffat
andrew.moffat@ed.ac.uk
44-131-650-9836
University of Edinburgh

Public Release: 8-Jan-2016
Scientific Reports
ASU scientists discover how blue and green clays kill bacteria
ASU scientists have discovered the two key ingredients that give some natural clays the power to kill even antibiotic-resistant microbes.
National Science Foundation

Contact: Robert Burnham
robert.burnham@asu.edu
480-458-8207
Arizona State University

Showing releases 201-225 out of 1226.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>